Mark Nitz
4Patents
1h-index
10Co-inventors
41Inventor score
Filing activity: Apr 25, 2003 → Sep 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10222380B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US7722890B2 | Synthetic anti-Candida albicans oligosaccharide based vaccines | Human Necessities | 1 | Expired |
| US10816552B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US12135325B2 | Organotellurium compounds, compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.